Chapter1. Introduction
1.1. Report Description And Scope
1.2. Research Scope
1.3. Research Methodology
1.3.1. Market Research Process
1.3.2. Market Research Methodology
Chapter2. Executive Summary
2.1. Global veterinary vaccine market, 2015 - 2021 (USD Billion)
2.2. Global veterinary vaccine market: Snapshot
Chapter3. Veterinary vaccine market Market Dynamics
3.1. Introduction
3.2. Value Chain Analysis
3.3. Market Drivers
3.3.1. Global veterinary vaccine market Drivers: Impact Analysis
3.3.2. New emerging technological advances in vaccine development and increasing awareness of animal care
3.3.3. Continuous development of drug resistance by microorganism and new emerging animal diseases
3.4. Market Restraints
3.4.1. Global veterinary vaccine market Restraints: Impact Analysis
3.4.2. High competition
3.5. Opportunities
3.5.1. Increasing investment by government of developing countries.
3.6. Porters Five Forces Analysis
3.6.1. Bargaining Power Of Suppliers
3.6.2. Bargaining Power Of Buyers
3.6.3. Threat From New Entrants
3.6.4. Threat From New Substitutes
3.6.5. Degree Of Competition
3.7. Market Attractiveness Analysis
3.7.1. Market Attractiveness Analysis, by Application segment
3.7.2. Market Attractiveness Analysis, by Technology segment
3.7.3. Market Attractiveness Analysis, By Regional Segment
Chapter4. Global veterinary vaccine market Competitive Landscape
4.1. Company Market Share, 2014 (Subject To Data Availability)
4.2. Strategic Development
4.2.1. Acquisitions Mergers
4.2.2. New Source Launch
4.2.3. Agreements, Partnerships, Collaborations And Joint Ventures
4.2.4. Research and Development, Product And Regional Expansion.
4.3. Product Portfolio
4.4. Patent Analysis (2011-2016)
4.4.1. Patent Trend
4.4.2. Patent Share By Company
4.4.3. By Region
Chapter5. Global veterinary vaccine market Product type Analysis
5.1. Global veterinary vaccine market: Product type Segment Overview
5.1.1. Global veterinary vaccine market Revenue Share, by Product type Segment, 2015 And 2021
5.2. Livestock vaccines
5.2.1. Global veterinary vaccine market for livestock vaccines , 2015 - 2021 (USD Billion)
5.3. Companion vaccines
5.3.1. Global veterinary vaccine market for Companion vaccine, 2015 - 2021 (USD Billion)
Chapter6. Global veterinary vaccine market Technology type Analysis
6.1. Global veterinary vaccine market: Technology type Segment Overview
6.1.1. Global veterinary vaccine market Revenue Share, By Technology type Segment, 2015 2021
6.2. Attenuated vaccines
6.2.1. Global veterinary vaccine market for Attenuated vaccines, 2015 - 2021 (USD Billion)
6.3. DNA Vaccines
6.3.1. Global veterinary vaccine market for DNA vaccines, 2015 - 2021 (USD Billion)
6.4. Inactivated vaccines
6.4.1. Global veterinary vaccine market for inactivated vaccines, 2015 - 2021 (USD Billion)
6.5. Toxoid vaccines
6.5.1. Global veterinary vaccine market for toxoid vaccines, 2015 - 2021 (USD Billion)
6.6. Recombinant vaccines
6.6.1. Global veterinary vaccine market for recombinant vaccines, 2015 - 2021 (USD Billion)
Chapter7. Global veterinary vaccine market Regional Segment Analysis
7.1. Global veterinary vaccine market: Regional Overview
7.1.1. Global veterinary vaccine market Revenue Share, By Region, 2014 And 2020
7.2. North America
7.2.1. North America veterinary vaccine market Revenue, by Product type classification, 2015 - 2021 , (USD Billion)
7.2.2. North America veterinary vaccine market Revenue, by Technology type 2015 - 2021 , (USD Billion)
7.2.3. U.S.
7.2.3.1. U.S. veterinary vaccine market revenue, by Product type, 2015 - 2021 , (USD Billion)
7.2.3.2. U.S. veterinary vaccine market revenue, by Technology type application 2015 - 2021 , (USD Billion)
7.3. Europe
7.3.1. Europe veterinary vaccine market revenue, by Product type, 2015 - 2021 (USD Billion)
7.3.2. Europe veterinary vaccine market revenue, by Technology type 2015 - 2021 , (USD Billion)
7.3.3. U.K.
7.3.3.1. U.K. veterinary vaccine market revenue, by Product type, 2015 - 2021 , (USD Billion)
7.3.3.2. U.K. veterinary vaccine market Revenue, by Technology type 2015 - 2021 , (USD Billion)
7.3.4. France
7.3.4.1. U.K. veterinary vaccine market revenue, by Product type, 2015 - 2021 , (USD Billion)
7.3.4.2. U.K. veterinary vaccine market revenue, by Technology type 2015 - 2021 , (USD Billion)
7.3.5. Germany
7.3.5.1. Germany veterinary vaccine market revenue, by Product type, 2015 - 2021 , (USD Billion)
7.3.5.2. Germany veterinary vaccine market revenue, by Technology type 2015 - 2021 , (USD Billion)
7.4. Asia Pacific
7.4.1. Asia Pacific veterinary vaccine market revenue, by Product type, 2015 - 2021 (USD Billion)
7.4.2. Asia Pacific veterinary vaccine market revenue, by Technology type Technology type 2015 - 2021 , (USD Billion)
7.4.3. China
7.4.3.1. China veterinary vaccine market revenue, by Product type, 2015 - 2021 , (USD Billion)
7.4.3.2. China veterinary vaccine market revenue, by Technology type Technology type 2015 - 2021 , (USD Billion)
7.4.4. Japan
7.4.4.1. Japan veterinary vaccine market revenue, by Product type, 2015 - 2021 , (USD Billion)
7.4.4.2. Japan veterinary vaccine market revenue, by Technology type Technology type 2015 - 2021 , (USD Billion)
7.4.5. India
7.4.5.1. India veterinary vaccine market revenue, by Product type, 2015 - 2021 , (USD Billion)
7.4.5.2. India veterinary vaccine market revenue, by Technology type Technology type 2015 - 2021 , (USD Billion)
7.5. Latin America
7.5.1. Latin America Veterinary vaccine market Revenue, by Product type, 2015 - 2021 (USD Billion)
7.5.2. Latin America veterinary vaccine market revenue, by Technology type Technology type 2015 - 2021 , (USD Billion)
7.5.3. Brazil
7.5.3.1. Brazil veterinary vaccine market revenue, by Product type, 2015 - 2021 , (USD Billion)
7.5.3.2. Brazil veterinary vaccine market revenue, by Technology type Technology type 2015 - 2021 , (USD Billion)
Chapter8. Company Profile
8.1. Teva Pharmaceutical Industries Ltd.
8.1.1. Overview
8.1.2. Financials
8.1.3. Product Portfolio
8.1.4. Business Strategy
8.1.5. Recent Developments
8.2. Novartis International AG.
8.2.1. Overview
8.2.2. Financials
8.2.3. Product Portfolio
8.2.4. Business Strategy
8.2.5. Recent Developments
8.3. Mylan N.V.
8.3.1. Overview
8.3.2. Financials
8.3.3. Product Portfolio
8.3.4. Business Strategy
8.3.5. Recent Developments
8.4. Abbott Healthcare Pvt Ltd.
8.4.1. Overview
8.4.2. Financials
8.4.3. Product Portfolio
8.4.4. Business Strategy
8.4.5. Recent Developments
8.5. Actavis pharmaceuticals Overview
8.5.1. Financials
8.5.2. Product Portfolio
8.5.3. Business Strategy
8.5.4. Recent Developments
8.6. Sun Pharmaceutical Industries Limited
8.6.1. Overview
8.6.2. Financials
8.6.3. Product Portfolio
8.6.4. Business Strategy
8.6.5. Recent Developments